Advertisement

Topics

Coherus BioSciences Inc CHRS Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

00:28 EST 24 Feb 2017 | BioPortfolio Reports

Summary

Coherus BioSciences Inc Coherus BioSciences focuses on the development and commercialization of biosimilar drugs. Its pipeline portfolio includes candidates such as CHS1701, is a pegfilgrastim used to treat febrile neutropenia, CHS0214, is an etanercept biosimilar candidate which is used for the treatment of ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis, psoriasis arthritis and rheumatoid arthritis and CHS1420, is a adalimumab biosimilar candidate,which is being developed to treat crohn's disease, ulcerative colitis and psoriasis arthritis, among others.Coherus BioSciences holds expertise in various areas such as process science, analytical characterization, protein production and clinicalregulatory development. The company develops drugs in collaboration with other organizations such as Baxalta and DaiichiSankyo, KBI Biopharma. Coherus BioSciences is headquartered in Redwood City, California, the US.

Coherus BioSciences Inc Key Recent Developments

Nov 09, 2016: Coherus BioSciences Reports Third Quarter 2016 Operating and Financial Results
Aug 09, 2016: Coherus Biosciences Reports Second Quarter 2016 Financial And Operating Results
May 16, 2016: Coherus Biosciences Appoints Patrick O'Brien As Senior Vice President, Investor Relations
May 09, 2016: Coherus Biosciences Reports First Quarter 2016 Financial And Operating Results
Feb 29, 2016: Coherus BioSciences Reports Fourth Quarter and Year End 2015 Financial and Operating Results

This comprehensive SWOT profile of Coherus BioSciences Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Coherus BioSciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*, x000D
x000D
Business description A detailed description of the company's operations and business divisions.x000D
Corporate strategy Analyst's summarization of the company's business strategy.x000D
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.x000D
Company history Progression of key events associated with the company.x000D
Major products and services A list of major products, services and brands of the company.x000D
Key competitors A list of key competitors to the company.x000D
Key employees A list of the key executives of the company.x000D
Executive biographies A brief summary of the executives' employment history.x000D
Key operational heads A list of personnel heading key departments/functions.x000D
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.x000D
Key manufacturing facilities A list of key manufacturing facilities of the company.x000D
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.x000D
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.x000D
x000D
Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,x000D
x000D
You get detailed information about the company and its operations to identify potential customers and suppliers.x000D
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.x000D
x000D
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.x000D
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. x000D
x000D
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.x000D
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.x000D
x000D
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.x000D
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.x000D
x000D
Gain key insights into the company for academic or business research.x000D
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Coherus BioSciences Inc CHRS Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "Coherus BioSciences Inc CHRS Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...